Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Peter I. Kalmar is active.

Publication


Featured researches published by Peter I. Kalmar.


Journal of the American College of Cardiology | 1983

Transesophageal two-dimensional echocardiography in the diagnosis of cor triatriatum in the adult.

Michael Schlüter; Burkhart A. Langenstein; Wolfgang Thier; Wolff-Helmut Schmiegel; Hans-Joachim Krebber; Peter I. Kalmar; Peter Hanrath

Two adult patients with left ventricular inflow obstruction are presented. Conventional two-dimensional echocardiography had failed to yield a definite diagnosis, whereas transesophageal two-dimensional echocardiography clearly documented a membraneous echo structure within the left atrium, diagnostic of cor triatriatum. On the basis of the transesophageal echocardiographic findings, left heart catheterization and angiocardiography were not performed and both patients successfully underwent cardiac surgery.


European Journal of Radiology | 2014

The impact of iterative reconstruction on image quality and radiation dose in thoracic and abdominal CT.

Peter I. Kalmar; Franz Quehenberger; Jürgen Steiner; Andre Lutfi; Dennis Bohlsen; Emina Talakic; Eva Hassler; Helmut Schöllnast

PURPOSE To compare the image quality and radiation dose between iterative reconstruction (IR) and standard filtered back projection (FBP) in CT of the chest and abdomen. MATERIALS AND METHODS Thoracic CT was performed in 50 patients (38 male, 12 female; mean age, 51 ± 23 yrs; range, 7-85 yrs) and abdominal CT was performed in 50 patients (36 male, 14 female; mean age, 62 ± 13 yrs; range, 20-85 yrs), using IR as well as FBP for image reconstruction. Image noise was quantitatively assessed measuring standard deviation of Hounsfield Units (HU) in defined regions of interest in subcutaneous tissue. Scan length and Computed Tomography Dose Index (CTDI) were documented. Scan length, image noise, and CTDI of both reconstruction techniques were compared by using paired tests according to the nature of variables (McNemar test or Student t test). Overall subjective image quality and subjective image noise were compared. RESULTS There was no significant difference between the protocols in terms of mean scan length (p>0.05). Image noise was statistically significantly higher with IR, although the difference was clinically insignificant (13.3 ± 3.0 HU and 13.6 ± 3.0 HU for thoracic CT and 11.5 ± 3.1 HU and 11.7 ± 3.0 HU for abdominal CT, p<0.05). There was no significant difference in overall subjective image quality and subjective image noise. The radiation dose was significantly lower with IR. Volume-weighted CTDI decreased by 64% (6.2 ± 2.5 mGy versus 17.1 ± 9.5 mGy, p<0.001) for thoracic CT and by 58% (7.8 ± 4.6 mGy versus 18.5 ± 8.6 mGy, p<0.001) for abdominal CT. CONCLUSIONS Our study shows that in thoracic and abdominal CT with IR, there is no clinically significant impact on image quality, yet a significant radiation dose reduction compared to FBP.


Journal of Vascular Access | 2014

The eternal tale of dialysis access vessels and restenosis: are drug-eluting balloons the solution?

Rupert H. Portugaller; Peter I. Kalmar; Hannes Deutschmann

In dialysis access fistulas and grafts, percutaneous transluminal angioplasty (PTA) is frequently followed by restenosis development, which results in repeated periodical re-interventions. The technique of drug-eluting balloon (DEB) angioplasty has shown promising results in the treatment of femoropopliteal arteriosclerotic lesions. In contrast to arteriosclerotic arteries, dialysis access vessels host unfavorable hemodynamics due to the direct conduction of high-pressure fluid into a low-pressure system. Hence, the beneficial effect of DEB angioplasty may be limited in this system. However, a first prospective randomized trial on 40 patients with arteriovenous fistula or graft stenoses exhibited a significantly higher 6-month primary patency of the treated lesions after DEB angioplasty than after uncoated balloon angioplasty. Despite such a positive reference, general recommendations regarding the value of DEBs in dialysis access vessels cannot be considered as serious unless large randomized controlled trials have been performed.


European Journal of Radiology | 2014

Gd-EOB-DTPA enhanced MRI of the liver: correlation of relative hepatic enhancement, relative renal enhancement, and liver to kidneys enhancement ratio with serum hepatic enzyme levels and eGFR.

Emina Talakic; Jürgen Steiner; Peter I. Kalmar; Andre Lutfi; Franz Quehenberger; Ursula Reiter; Michael Fuchsjäger; Helmut Schöllnast

OBJECTIVES To assess the correlation of relative hepatic enhancement (RHE), relative renal enhancement (RRE) and liver to kidneys enhancement ratio (LKR) with serum hepatic enzyme levels and eGFR in Gd-EOB-DTPA enhanced MRI of the liver and to assess threshold levels for predicting enhancement of the liver parenchyma. METHODS Data of 75 patients who underwent Gd-EOB-DTPA enhanced MRI of the liver were collected. Images were obtained before contrast injection, during the early arterial phase, late arterial phase, venous phase, delayed phase, and hepatobiliary phase which was 20 min after Gd-EOB-DTPA administration. Signal intensity of the liver and the kidneys in all phases was defined using region-of-interest measurements for relative enhancement calculation. Serum hepatic enzyme levels and eGFR were available in all patients. Spearman correlation test was used to test the correlation of RHE, RRE and LKR with serum hepatic enzyme levels and eGFR. RESULTS In the hepatobiliary phase all serum hepatic enzymes were significantly correlated with RHE; total bilirubin (TBIL) and cholin esterase (CHE) showed strongest correlations. TBIL and CHE were significantly correlated with RRE in the arterial phases. TBIL and CHE were significantly correlated with LKR in the arterial phase and hepatobiliary phase. eGFR showed no correlation. CONCLUSIONS In Gd-EOB-DTPA enhanced MRI, TBIL and CHE levels may predict RHE, RRE and LKR.


Clinical Orthopaedics and Related Research | 2016

Is Embolization an Effective Treatment for Recurrent Hemorrhage After Hip or Knee Arthroplasty

Peter I. Kalmar; Andreas Leithner; Reinhard Ehall; Rupert H. Portugaller

BackgroundSpontaneous recurrent hemorrhage after arthroplasty of the hip or knee is a rare condition. In patients who do not have coagulopathy, the likeliest etiology for hemarthrosis is hypertrophic vascular synovium. Treatments include arthroscopic or open synovectomy, or angiography with embolization; however, because the condition is rare, seldom reported, and debilitating, small case series characterizing the efficacy of any approach are important to allow a collective experience with this condition to emerge.Questions/purposesWe attempted to (1) determine whether angiography with embolization can prevent recurrent hemarthrosis after hip or knee arthroplasty in a small series of patients with or without coagulopathy, and (2) evaluate complications associated with this intervention.MethodsBetween 2005 and 2014, seven patients presented with spontaneous, recurrent hemarthroses. One patient had polycythemia vera and factor XIII deficiency as underlying illnesses. All patients were treated with selective transarterial embolization, and all had followup at a minimum of 12 months (range, 12–102 months; median, 74 months). Other treatments during this time included hematoma removals and flap operations in one patient, and indications for transarterial embolization included recurrent hemarthrosis. The patients included six men and one woman with a median age of 72 years (range, 61–78 years). Five patients underwent one or more reoperations before transarterial embolization. A diagnostic workup for coagulopathy was performed in all patients; one patient was identified to have polycythemia ruba vera and factor XIII deficiency, however the patient still was treated with transarterial embolization because it was perceived to be the least invasive of available options. No other patients had a diagnosis of coagulopathy. Angiography showed hypervascularity in all patients and a contrast agent showed extravasation in two. Selective transarterial embolization of branches of the internal iliac artery, common femoral artery, deep femoral artery, or the popliteal artery was performed with polyvinyl alcohol particles, microspheres, and/or coils. Patients were followed clinically during 12 to 102 months (median, 74 months) to determine whether the hemorrhages recurred.ResultsTechnical success was achieved in all patients. No procedure-related complications were reported. On followup, recurrent hemorrhage was reported in one patient who had a diagnosis of coagulopathy before the procedure. He underwent three reinterventions and five reoperations. Three months after initial embolization, a flap procedure was performed.ConclusionsIn a small series of patients with a minimum followup of 1 year, we found selective transarterial embolization to be effective in patients without underlying coagulopathy in preventing recurrences of spontaneous recurrent hematoma or hemarthrosis of the hip and the knee. This condition is rare, therefore comparative trials are unlikely to be done. Because transarterial embolization is relatively low risk and generally well tolerated, we consider it to be a reasonable approach for consideration with other options such as arthroscopic or open synovectomy and revision arthroplasty.Level of EvidenceLevel IV, therapeutic study.


European Journal of Clinical Nutrition | 2014

Primary epiploic appendagitis and fructose malabsorption.

Wolfgang J. Schnedl; Rainer W. Lipp; Peter I. Kalmar; Szolar Dh; H. Mangge

Primary epiploic appendagitis (PEA) is a rare cause of abdominal acute or subacute complaints. Diagnosis of PEA is made when computed tomography (CT) reveals a characteristic lesion. We report on contrast-enhanced CT images of a patient with PEA and regression of inflammation and the reduction in size of the inflamed appendage over the time period of 4 months. Patients with PEA usually recover without medication or surgical treatment within a few weeks. However, due to continuing bloating and irregular bowel movements we investigated carbohydrate malabsorption and diagnosed a fructose malabsorption. Bloating and irregular bowel movements in this patient with PEA were correlated to carbohydrate malabsorption and were treated successfully with a diet free of culprit carbohydrates.


European Journal of Radiology | 2014

Placement of hemoparin-coated stents in the iliac arteries: Early experience and midterm results in 28 patients

Peter I. Kalmar; Rupert H. Portugaller; Peter Schedlbauer; Dennis Bohlsen; Hannes Deutschmann

PURPOSE Aim was to determine immediate results and mid-term outcome of the hemoparin-coated (HC) stainless-steel stent (camouflage coating) in the treatment of occlusive lesions of the iliac arteries. MATERIALS AND METHODS Twenty-eight patients were prospectively treated with the use of a HC stent between January 2007 and March 2010. Clinical examination and color-doppler ultrasound were performed at 1, 3, 6 and 12 months, CT angiography (CTA) or MR angiography (MRA) at 12 months. Indication for treatment was a high-grade stenosis of the common iliac and/or external iliac artery. RESULTS Successful placement was achieved in all patients. Significant decrease in translesional pressure gradient (>10 mm Hg) was measured in 27 patients (96%). In one patient, proximal dissection occurred without flow limitation. A minor complication (small access site hematoma) occurred in one patient (4%). Two patients (7%) were lost to follow-up. After 12 months, stent patency in CTA, MRA and ultrasound was 100%. 20 patients (77%) experienced an initial improvement of at least one clinical stage. In one patient (4%), mild intimal hyperplasia without significant stenosis was observed. In three patients (12%), proximal or distal stenosis occurred. A non-significant increase of mean ankle-brachial index (ABI) after treatment was measured (0.85 ± 0.27 vs. 0.75 ± 0.22, respectively; p=0.328). CONCLUSIONS The use of HC stents in patients with iliac artery occlusive disease may lead to a lower rate of intimal hyperplasia and thus to increased patency rates even in heavily calcified vessels. However, large-scale prospective trials have to be performed to evaluate the long-term patency rates of the HC coated stents.


Rofo-fortschritte Auf Dem Gebiet Der Rontgenstrahlen Und Der Bildgebenden Verfahren | 2017

CT-Diagnostik der inneren Hernie nach antekolischem Roux-en-Y-Magenbypass bei bariatrischen Patienten

Robert Konrad Vollmann; Philipp Beckerhinn; Peter I. Kalmar; Jessica Vollmann; Hans-Peter Sochor

Überhöhtes Körpergewicht stellt in der Europäischen Region der WHO eines der schwerwiegendsten Probleme für die öffentliche Gesundheit im 21. Jahrhundert dar. Die Prävalenz der Adipositas hat sich hier in den letzten beiden Jahrzehnten verdreifacht und mittlerweile epidemische Ausmaße erreicht. Bei Erwachsenen beginnt Übergewicht ab einem Körpermasseindex (BMI) = 25 kg/m2. Von Adipositas wird bei einem BMI ≥ 30 kg/m2 gesprochen. Erwachsene mit einem BMI von 25,0 –29,9 kg/m2 werden als präadipös bezeichnet (WHO. Die Herausforderung Adipositas und Strategien zu ihrer Bekämpfung; 2006). Die bariatrische Chirurgie ist sicherlich die invasivste aber auch effektivste Form der Therapie bei Adipositas. Aus diesem Grund ist sie nur für selektionierte Fälle vorgesehen. Nichtsdestotrotz ist die Anzahl der bariatrischen Eingriffe stark gestiegen. Alleine in den USA konnte man zwischen 1998 und 2003 eine Verfünffachung dieser Operationen erkennen (Santry HP et al. JAMA 2005; 294: 1909 – 1917). Die Indikation zur Operation besteht ab einem BMI von 40 kg/m2 beziehungsweise ab 35 kg/m2 bei gleichzeitig bestehenden Komorbiditäten gemäß der IFSO-Guidelines.


Clinical Imaging | 2016

Gadolinium-free MR in coarctation-can contrast-enhanced MR angiography be replaced?

Peter I. Kalmar; Martin Koestenberger; Robert Marterer; Sebastian Tschauner; Erich Sorantin

OBJECTIVE To determine the difference in vessel measurements, signal-to-noise ratio (SNR), and voxel size between contrast-enhanced and noncontrast magnetic resonance techniques in patients with coarctation of the aorta (CoA). MATERIALS AND METHODS In 39 patients, vessel size, SNR, and voxel size were compared in cine magnetic resonance imaging (MRI), gadolinium-free magnetic resonance angiography (Gd-free MRA), and contrast-enhanced MRA (ce-MRA). RESULTS There was no significant difference in measurement and SNR, but there was a significant difference in voxel size (P<.001). CONCLUSIONS Our results show that, in CoA patients, monitoring of vessel size using cine MRI and Gd-free MRA is equivalent to ce-MRA while being less invasive.


World Journal of Gastroenterology | 2015

Co-occurrence of carbohydrate malabsorption and primary epiploic appendagitis.

Wolfgang J. Schnedl; Peter I. Kalmar; Harald Mangge; Robert Krause

Unspecific abdominal complaints including bloating and irregular bowel movements may be caused by carbohydrate malabsorption syndromes, e.g., lactose and fructose malabsorption. These symptoms were investigated with hydrogen (H2) breath tests and correlated to carbohydrate malabsorption. During performing these H2-breath tests the patient presented with an acute, localized, non-migratory pain in the left lower abdominal quadrant. Primary epiploic appendagitis is a rare cause of abdominal acute or subacute complaints and diagnosis of primary epiploic appendagitis (PEA) is made when computed tomography reveals a characteristic lesion. We report on a patient with co-occurrence of lactose and fructose malabsorption, which was treated successfully with a diet free of culprit carbohydrates, with PEA recovering without medication or surgical treatment within few days. Since the abdominal unspecific symptoms had been present for months, they appeared not to be correlated to the acute localized abdominal pain, therefore we speculate on a random co-occurrence of combined carbohydrate malabsorption and PEA.

Collaboration


Dive into the Peter I. Kalmar's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Emina Talakic

Medical University of Graz

View shared research outputs
Top Co-Authors

Avatar

Jürgen Steiner

Medical University of Graz

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Peter Schedlbauer

Medical University of Graz

View shared research outputs
Top Co-Authors

Avatar

Andre Lutfi

Medical University of Graz

View shared research outputs
Top Co-Authors

Avatar

Dennis Bohlsen

Medical University of Graz

View shared research outputs
Researchain Logo
Decentralizing Knowledge